D
Microbot Medical Inc.
MBOT
$1.54
$0.106.94%
D
Sell
2/5/2025Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 2/5/2025 due to an increase in the volatility index, total return index and growth index.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 2/5/2025 due to an increase in the volatility index, total return index and growth index.
E
Sell
1/21/2025Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 1/21/2025 due to a decline in the volatility index and valuation index.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 1/21/2025 due to a decline in the volatility index and valuation index.
D
Sell
1/6/2025Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 1/6/2025 due to an increase in the volatility index and total return index.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 1/6/2025 due to an increase in the volatility index and total return index.
E
Sell
4/12/2024Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 4/12/2024 due to a decline in the volatility index.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 4/12/2024 due to a decline in the volatility index.
D
Sell
3/28/2024Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 3/28/2024 due to an increase in the volatility index.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 3/28/2024 due to an increase in the volatility index.
E
Sell
3/15/2024Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 3/15/2024 due to a decline in the volatility index and growth index.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 3/15/2024 due to a decline in the volatility index and growth index.
D
Sell
1/8/2024Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 1/8/2024 due to an increase in the volatility index and total return index.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 1/8/2024 due to an increase in the volatility index and total return index.
E
Sell
12/22/2023Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 12/22/2023 due to a decline in the growth index, total return index and volatility index. EBIT declined 9.47% from -$2.32M to -$2.54M.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 12/22/2023 due to a decline in the growth index, total return index and volatility index. EBIT declined 9.47% from -$2.32M to -$2.54M.
D
Sell
8/18/2023Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 8/18/2023 due to a noticeable increase in the growth index, solvency index and total return index. The quick ratio increased from 4.1 to 7.49, debt to equity declined from 0.05 to 0.02, and operating cash flow increased 42.12% from -$3.2M to -$1.85M.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 8/18/2023 due to a noticeable increase in the growth index, solvency index and total return index. The quick ratio increased from 4.1 to 7.49, debt to equity declined from 0.05 to 0.02, and operating cash flow increased 42.12% from -$3.2M to -$1.85M.
E
Sell
4/6/2023Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 4/6/2023 due to a decline in the total return index and volatility index.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 4/6/2023 due to a decline in the total return index and volatility index.
D
Sell
3/29/2023Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 3/29/2023 due to an increase in the valuation index.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 3/29/2023 due to an increase in the valuation index.
E
Sell
3/14/2023Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index and volatility index.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/23/2023Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 2/23/2023 due to an increase in the valuation index.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 2/23/2023 due to an increase in the valuation index.
E
Sell
2/8/2023Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.03 to 0.05, and the quick ratio declined from 5.39 to 3.84.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.03 to 0.05, and the quick ratio declined from 5.39 to 3.84.
D
Sell
8/18/2022Downgrade
Microbot Medical Inc. (MBOT) was downgraded to D- from D on 8/18/2022 due to a noticeable decline in the growth index, valuation index and total return index. EBIT declined 12.19% from -$3.18M to -$3.56M, earnings per share declined from -$0.4486 to -$0.4942, and operating cash flow declined 3.89% from -$3.01M to -$3.12M.
Microbot Medical Inc. (MBOT) was downgraded to D- from D on 8/18/2022 due to a noticeable decline in the growth index, valuation index and total return index. EBIT declined 12.19% from -$3.18M to -$3.56M, earnings per share declined from -$0.4486 to -$0.4942, and operating cash flow declined 3.89% from -$3.01M to -$3.12M.
D
Sell
5/23/2022Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D from D- on 5/23/2022 due to a noticeable increase in the growth index and valuation index. EBIT increased 19.33% from -$3.94M to -$3.18M, and earnings per share increased from -$0.5429 to -$0.4486.
Microbot Medical Inc. (MBOT) was upgraded to D from D- on 5/23/2022 due to a noticeable increase in the growth index and valuation index. EBIT increased 19.33% from -$3.94M to -$3.18M, and earnings per share increased from -$0.5429 to -$0.4486.
D
Sell
4/20/2022Downgrade
Microbot Medical Inc. (MBOT) was downgraded to D- from D on 4/20/2022 due to a large decline in the total return index, growth index and solvency index. Debt to equity increased from 0.01 to 0.02, EBIT declined 54.27% from -$2.55M to -$3.94M, and earnings per share declined from -$0.3594 to -$0.5429.
Microbot Medical Inc. (MBOT) was downgraded to D- from D on 4/20/2022 due to a large decline in the total return index, growth index and solvency index. Debt to equity increased from 0.01 to 0.02, EBIT declined 54.27% from -$2.55M to -$3.94M, and earnings per share declined from -$0.3594 to -$0.5429.
D
Sell
11/18/2021Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D from D- on 11/18/2021 due to an increase in the growth index and total return index. Operating cash flow increased 5.27% from -$2.3M to -$2.18M.
Microbot Medical Inc. (MBOT) was upgraded to D from D- on 11/18/2021 due to an increase in the growth index and total return index. Operating cash flow increased 5.27% from -$2.3M to -$2.18M.
D
Sell
11/8/2021Downgrade
Microbot Medical Inc. (MBOT) was downgraded to D- from D on 11/8/2021 due to a decline in the efficiency index, growth index and solvency index. Operating cash flow declined 15.2% from -$1.99M to -$2.3M, total capital declined 9.72% from $23.07M to $20.83M, and net income declined 5.15% from -$2.39M to -$2.51M.
Microbot Medical Inc. (MBOT) was downgraded to D- from D on 11/8/2021 due to a decline in the efficiency index, growth index and solvency index. Operating cash flow declined 15.2% from -$1.99M to -$2.3M, total capital declined 9.72% from $23.07M to $20.83M, and net income declined 5.15% from -$2.39M to -$2.51M.
D
Sell
4/15/2020Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D from D- on 4/15/2020 due to a noticeable increase in the growth index, valuation index and volatility index. Earnings per share increased from -$0.435 to -$0.4301.
Microbot Medical Inc. (MBOT) was upgraded to D from D- on 4/15/2020 due to a noticeable increase in the growth index, valuation index and volatility index. Earnings per share increased from -$0.435 to -$0.4301.
D
Sell
1/17/2020Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 1/17/2020 due to an increase in the total return index and volatility index.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 1/17/2020 due to an increase in the total return index and volatility index.
E
Sell
12/18/2019Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 12/18/2019 due to a decline in the valuation index and total return index.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 12/18/2019 due to a decline in the valuation index and total return index.
D
Sell
12/3/2019Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 12/3/2019 due to an increase in the total return index and valuation index.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 12/3/2019 due to an increase in the total return index and valuation index.
E
Sell
11/15/2019Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 11/15/2019 due to a decline in the growth index, solvency index and valuation index. Operating cash flow declined 179.04% from -$477 to -$1.33M, debt to equity increased from 0.04 to 0.05, and earnings per share declined from -$0.358 to -$0.44.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 11/15/2019 due to a decline in the growth index, solvency index and valuation index. Operating cash flow declined 179.04% from -$477 to -$1.33M, debt to equity increased from 0.04 to 0.05, and earnings per share declined from -$0.358 to -$0.44.
D
Sell
8/19/2019Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 8/19/2019 due to an increase in the growth index. Operating cash flow increased 82.48% from -$2.72M to -$477, earnings per share increased from -$0.4799 to -$0.36, and EBIT increased 19.36% from -$1.92M to -$1.55M.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 8/19/2019 due to an increase in the growth index. Operating cash flow increased 82.48% from -$2.72M to -$477, earnings per share increased from -$0.4799 to -$0.36, and EBIT increased 19.36% from -$1.92M to -$1.55M.
E
Sell
7/12/2019Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 7/12/2019 due to a decline in the total return index and volatility index.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 7/12/2019 due to a decline in the total return index and volatility index.
D
Sell
5/17/2019Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 5/17/2019 due to an increase in the solvency index, valuation index and growth index. The quick ratio increased from 1.11 to 1.77, earnings per share increased from -$0.7068 to -$0.48, and EBIT increased 8.06% from -$2.08M to -$1.92M.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 5/17/2019 due to an increase in the solvency index, valuation index and growth index. The quick ratio increased from 1.11 to 1.77, earnings per share increased from -$0.7068 to -$0.48, and EBIT increased 8.06% from -$2.08M to -$1.92M.
E
Sell
5/16/2019Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 5/16/2019 due to a decline in the total return index.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 5/16/2019 due to a decline in the total return index.
D
Sell
4/18/2019Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 4/18/2019 due to an increase in the total return index, valuation index and volatility index.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 4/18/2019 due to an increase in the total return index, valuation index and volatility index.
E
Sell
4/3/2019Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 4/3/2019 due to a noticeable decline in the growth index, valuation index and solvency index. The quick ratio declined from 11.98 to 1.1, EBIT declined 18.88% from -$1.75M to -$2.08M, and operating cash flow declined 7.73% from -$1.33M to -$1.44M.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 4/3/2019 due to a noticeable decline in the growth index, valuation index and solvency index. The quick ratio declined from 11.98 to 1.1, EBIT declined 18.88% from -$1.75M to -$2.08M, and operating cash flow declined 7.73% from -$1.33M to -$1.44M.
D
Sell
2/25/2019Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 2/25/2019 due to an increase in the valuation index, total return index and volatility index.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 2/25/2019 due to an increase in the valuation index, total return index and volatility index.
E
Sell
2/7/2019Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 2/7/2019 due to a decline in the valuation index.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 2/7/2019 due to a decline in the valuation index.
D
Sell
1/23/2019Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 1/23/2019 due to an increase in the growth index, valuation index and volatility index. EBIT increased 7.35% from -$1.89M to -$1.75M, and operating cash flow increased 1.26% from -$1.35M to -$1.33M.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 1/23/2019 due to an increase in the growth index, valuation index and volatility index. EBIT increased 7.35% from -$1.89M to -$1.75M, and operating cash flow increased 1.26% from -$1.35M to -$1.33M.
E
Sell
8/17/2018Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 8/17/2018 due to a decline in the growth index, solvency index and efficiency index. The quick ratio declined from 20.21 to 13.83, net income declined 28.86% from -$1.47M to -$1.89M, and EBIT declined 24.88% from -$1.52M to -$1.89M.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 8/17/2018 due to a decline in the growth index, solvency index and efficiency index. The quick ratio declined from 20.21 to 13.83, net income declined 28.86% from -$1.47M to -$1.89M, and EBIT declined 24.88% from -$1.52M to -$1.89M.
D
Sell
6/14/2018Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 6/14/2018 due to an increase in the volatility index, valuation index and total return index.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 6/14/2018 due to an increase in the volatility index, valuation index and total return index.
E
Sell
5/30/2018Downgrade
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 5/30/2018 due to a decline in the efficiency index, volatility index and valuation index. Total capital declined 10.57% from $9.96M to $8.91M.
Microbot Medical Inc. (MBOT) was downgraded to E+ from D- on 5/30/2018 due to a decline in the efficiency index, volatility index and valuation index. Total capital declined 10.57% from $9.96M to $8.91M.
D
Sell
4/13/2018Upgraded
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 4/13/2018 due to an increase in the valuation index, solvency index and volatility index.
Microbot Medical Inc. (MBOT) was upgraded to D- from E+ on 4/13/2018 due to an increase in the valuation index, solvency index and volatility index.
E
Sell
8/1/2017Upgraded
Microbot Medical Inc. (MBOT) was upgraded to E+ from E on 8/1/2017 due to an increase in the valuation index, growth index and solvency index. EBIT increased 84.42% from -$7.91M to -$1.23M, earnings per share increased from -$0.2122 to -$0.04, and the quick ratio increased from 3.48 to 6.15.
Microbot Medical Inc. (MBOT) was upgraded to E+ from E on 8/1/2017 due to an increase in the valuation index, growth index and solvency index. EBIT increased 84.42% from -$7.91M to -$1.23M, earnings per share increased from -$0.2122 to -$0.04, and the quick ratio increased from 3.48 to 6.15.
E
Sell
5/1/2017Upgraded
Microbot Medical Inc. (MBOT) was upgraded to E from E- on 5/1/2017 due to an increase in the efficiency index, growth index and solvency index. Total capital increased 667.1% from $231 to $1.77M, the quick ratio increased from 1.39 to 3.48, and operating cash flow increased 95.56% from -$421.5 to -$18.7.
Microbot Medical Inc. (MBOT) was upgraded to E from E- on 5/1/2017 due to an increase in the efficiency index, growth index and solvency index. Total capital increased 667.1% from $231 to $1.77M, the quick ratio increased from 1.39 to 3.48, and operating cash flow increased 95.56% from -$421.5 to -$18.7.
E
Sell
2/24/2017None
Microbot Medical Inc. (MBOT) was downgraded to E- from U on 02/24/2017.
Microbot Medical Inc. (MBOT) was downgraded to E- from U on 02/24/2017.
NASDAQ
03/14/2025 4:00PM Eastern
Quotes delayed
